Pitavastatin Calcium Pentahydrate is an HMG-CoA reductase inhibitor belonging to the statin class of pharmaceuticals, widely prescribed to manage hyperlipidemia by lowering serum cholesterol levels and… Read more
Pitavastatin Calcium Pentahydrate is an HMG-CoA reductase inhibitor belonging to the statin class of pharmaceuticals, widely prescribed to manage hyperlipidemia by lowering serum cholesterol levels and reducing the risk of cardiovascular events such as myocardial infarction and stroke. Laboratories utilize reference standards for Pitavastatin Calcium Pentahydrate, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds, to support rigorous analytical testing and quality control processes. These high-quality reference materials are essential for accurate impurity profiling, method validation, and the precise quantification of the active pharmaceutical ingredient during stability testing. By providing reliable benchmarks for identifying degradation products and metabolic pathways, these analytical standards help ensure the safety and efficacy of the drug throughout the development and manufacturing lifecycle.